🇺🇸 Psychopharmacological treatment in United States
4 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 4
Most-reported reactions
- Drug Abuse — 1 report (25%)
- Intentional Self-Injury — 1 report (25%)
- Loss Of Consciousness — 1 report (25%)
- Sopor — 1 report (25%)
Other Psychiatry/Mental Health approved in United States
Frequently asked questions
Is Psychopharmacological treatment approved in United States?
Psychopharmacological treatment does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Psychopharmacological treatment in United States?
Hospital Universitari Vall d'Hebron Research Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.